Imidazopyridines
Medchemexpress LLC CXCR7 modulator 1 (compound 25) | 2231812-31-8 | 99.5% | 914.07 | C48H57F2N7O7S | 100 MG
CXCR7 modulator 1 is a potent, orally bioavailable peptoid-hybrid small molecule that modulates the chemokine receptor CXCR7 (reported Ki = 9 nM). It is intended for research use in studies of GPCR signaling and immunology/inflammation.
- Potent CXCR7 modulator with reported Ki of 9 nM.
- Orally bioavailable peptoid-hybrid small molecule.
- Peptoid-hybrid scaffold suitable for medicinal chemistry studies.
- High purity (99.5%) for research applications.
- Molecular weight 914.07, molecular formula C48H57F2N7O7S.
- Suitable for GPCR signaling and immunology or inflammation research.
Medchemexpress LLC CXCR7 antagonist-1 | 2990472-61-0 | 99.4% | C21H20ClFN6O | 10MG
CXCR7 antagonist-1 hydrochloride is a small-molecule antagonist of the chemokine receptor CXCR7 that inhibits binding of the chemokines SDF-1 (CXCL12) and I-TAC (CXCL11). It is supplied as the hydrochloride salt for research use in studies of tumor cell proliferation, tumor formation, and inflammatory disease pathways.
- Antagonist of the CXCR7 chemokine receptor.
- Inhibits SDF-1 (CXCL12) and I-TAC (CXCL11) binding to CXCR7.
- Provided as the hydrochloride salt in a solid form.
- High purity (99.4%).
- Supplied in small research-scale quantities suitable for in vitro assays.
Medchemexpress LLC IL-17A modulator-2 | 2748749-47-3 | 98.4% | 577.63 | C33H31N5O5 | 5 MG
IL-17A modulator-2 is a small-molecule research compound that inhibits the biological activity of interleukin-17A. Reported from patent WO2021239743 (example 27), it is intended for use in preclinical studies investigating immune-related, autoimmune, cancer, and neurodegenerative disorders.
- Inhibits interleukin-17A with a reported pIC50 of 8.3.
- High purity suitable for research applications (≈98.4%).
- Molecular weight 577.63; formula C33H31N5O5.
- Available in small quantities appropriate for in vitro assays.
- Reportedly derived from a patent example, supporting reproducible synthesis.
- Intended for research use only; not for human therapeutic use.
Medchemexpress LLC Olprinone Hydrochloride | 119615-63-3 | 99.9% | C14H11ClN4O | 100 MG
Olprinone Hydrochloride is a potent phosphodiesterase (PDE) 3 inhibitor, with IC50s of 0.35 μM for PDE3. It is used for the research of heart failure due to its positive inotropic and vasodilative effects, and also exhibits anti-inflammatory activity.
- Potent phosphodiesterase 3 inhibitor
- Exhibits positive inotropic and vasodilative effects
- Shows anti-inflammatory activity
- Suitable for heart failure research
- Reduces myocardial injury in vivo
Aobchem 6-(Dimethylamino)pyridine-3-boronic acid pinacol ester | ≥97% | CAS 1036991-24-8 | C13H21BN2O2 | 5g
6-(Dimethylamino)pyridine-3-boronic acid pinacol ester | ≥97% | CAS 1036991-24-8 | C13H21BN2O2 | 5g
Aobchem Pyridine 3-bromo-2-(cyclohexyloxy)- | ≥95% | CAS 52200-50-7 | C11H14BrNO | 25g
Pyridine 3-bromo-2-(cyclohexyloxy)- | ≥95% | CAS 52200-50-7 | C11H14BrNO | 25g
![eMolecules 1092351-65-9 | 5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502189595.JPG-250.jpg)
eMolecules 1092351-65-9 | 5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079
5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | 1092351-65-9 | MFCD11109379 | 255.071 | C9H7BrN2O2 | 98.000 | COC(=O)c1cn2c(Br)cccc2n1 | 1g | 603154079